PDS Biotechnology (FRA:EU6) Buyback Yield %: -17.27 (As of Jul. 12, 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
31 GF Score
Price €0.68
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Buyback Yield %?

PDS Biotechnology FRA:EU6 -5.59% 31 Buyback Yield % is -17.27 as of Jul. 12, 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, PDS Biotechnology ranks worse than 64.69% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

PDS Biotechnology's current buyback yield was -17.27%.


PDS Biotechnology Buyback Yield % Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology Buyback Yield % Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.87 -2.58 -9.79 -34.96 -32.19

PDS Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.23 -19.13 -27.37 -33.10 -22.26

FRA:EU6 vs LTRN, AURX, VERU: Buyback Yield % Comparison

For the Biotechnology subindustry, PDS Biotechnology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PDS Biotechnology Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Buyback Yield % falls into.


FRA:EU6
31GF Score
PDS Biotechnology Corp FRA:EU6
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

PDS Biotechnology's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 11.941) / 37.097528
=-32.19%

PDS Biotechnology's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 6.446) / 25.9321136
=-24.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -17.27 mean?
PDS Biotechnology (FRA:EU6) has a Buyback Yield % of -17.27 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PDS Biotechnology and its competitors. According to the industry distribution chart, PDS Biotechnology ranks #480 out of 742 companies in the Biotechnology industry, placing it in the top 64.7%.
Is PDS Biotechnology's Buyback Yield % too high?
PDS Biotechnology's current Buyback Yield % is -17.27. Based on the distribution chart, PDS Biotechnology ranks #480 out of 742 companies in the Biotechnology industry, which is below the industry midpoint. Overall, PDS Biotechnology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's Buyback Yield % compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #480 out of 742 companies for Buyback Yield %. This places PDS Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current Buyback Yield % is -17.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current Buyback Yield % of -17.27. The current Buyback Yield % is -17.27. PDS Biotechnology's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Buyback Yield % is -17.27 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
31GF Score

Get the complete analysis for FRA:EU6

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.68
Price